Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 09, 2025 21:50 ET | Source: Wave Life Sciences USA, Inc.…
Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock
December 09, 2025 21:42 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass.,…
Iridium Appoints Louis Alterman to Board of Directors
MCLEAN, Va., Dec. 4, 2025 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq: IRDM),…
Iridium Awarded 5-Year System Infrastructure Transformation and Hybridization Contract Worth Up to $85.8 Million
New Contract Supports Enhancements to the Iridium and U.S. DoD EMSS Service…
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
BEIJING, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2025 08:00 ET | Source: UroGen Pharma Ltd. PRINCETON, N.J.,…
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease
December 05, 2025 08:00 ET | Source: Amneal Pharmaceuticals LLC Interim data…
PDF Solutions to Make Its Analyst Day Webcast and Presentation Available
Company Also Reaffirms 2025 Financial Outlook December 01, 2025 19:01 ET |…
Fusemachines Files Q3 2025 Quarterly Report and Discloses Nasdaq Notice
November 28, 2025 16:05 ET | Source: Fusemachines NEW YORK, Nov. 28,…
Eisai Submits New Drug Application for Subcutaneous Formulation of LEQEMBI for the Treatment of Early Alzheimers Disease in Japan
If approved, lecanemab would be the first and only anti-amyloid treatment in…